251 related articles for article (PubMed ID: 26521302)
1. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
Guo L; Shestov AA; Worth AJ; Nath K; Nelson DS; Leeper DB; Glickson JD; Blair IA
J Biol Chem; 2016 Jan; 291(1):42-57. PubMed ID: 26521302
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Succinate in Cardiac Ischemia Primarily Occurs via Canonical Krebs Cycle Activity.
Zhang J; Wang YT; Miller JH; Day MM; Munger JC; Brookes PS
Cell Rep; 2018 May; 23(9):2617-2628. PubMed ID: 29847793
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells.
Caneba CA; Yang L; Baddour J; Curtis R; Win J; Hartig S; Marini J; Nagrath D
Cell Death Dis; 2014 Jun; 5(6):e1302. PubMed ID: 24967964
[TBL] [Abstract][Full Text] [Related]
4. NADPH-The Forgotten Reducing Equivalent.
Chandel NS
Cold Spring Harb Perspect Biol; 2021 Jun; 13(6):. PubMed ID: 34074675
[No Abstract] [Full Text] [Related]
5. Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.
Orlovskiy S; Gupta PK; Roman J; Arias-Mendoza F; Nelson DS; Koch CJ; Narayan V; Putt ME; Nath K
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611062
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.
Nancolas B; Guo L; Zhou R; Nath K; Nelson DS; Leeper DB; Blair IA; Glickson JD; Halestrap AP
Biochem J; 2016 Apr; 473(7):929-36. PubMed ID: 26831515
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antineoplastic activity of lonidamine.
Nath K; Guo L; Nancolas B; Nelson DS; Shestov AA; Lee SC; Roman J; Zhou R; Leeper DB; Halestrap AP; Blair IA; Glickson JD
Biochim Biophys Acta; 2016 Dec; 1866(2):151-162. PubMed ID: 27497601
[TBL] [Abstract][Full Text] [Related]
8. Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by 13C NMR Spectroscopy of Perfused Tumor Cells.
Shestov AA; Mancuso A; Lee SC; Guo L; Nelson DS; Roman JC; Henry PG; Leeper DB; Blair IA; Glickson JD
J Biol Chem; 2016 Mar; 291(10):5157-71. PubMed ID: 26703469
[TBL] [Abstract][Full Text] [Related]
9. SnapShot: Hypoxia-Inducible Factors.
Lee KE; Simon MC
Cell; 2015 Nov; 163(5):1288-1288.e1. PubMed ID: 26590427
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of NADH and ROS production by respiratory complex I.
Vinogradov AD; Grivennikova VG
Biochim Biophys Acta; 2016 Jul; 1857(7):863-71. PubMed ID: 26571336
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells.
Ma S; Jia R; Li D; Shen B
Biomed Res Int; 2015; 2015():453986. PubMed ID: 26558272
[TBL] [Abstract][Full Text] [Related]
12. The Role of Pyruvate Kinase M2 in Cancer Metabolism.
Liu VM; Vander Heiden MG
Brain Pathol; 2015 Nov; 25(6):781-3. PubMed ID: 26526946
[TBL] [Abstract][Full Text] [Related]
13. Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine.
Bhutia YD; Babu E; Ganapathy V
Biochem J; 2016 Jun; 473(11):1503-6. PubMed ID: 27234586
[TBL] [Abstract][Full Text] [Related]
14. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
[TBL] [Abstract][Full Text] [Related]
15. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.
Cheng G; Zhang Q; Pan J; Lee Y; Ouari O; Hardy M; Zielonka M; Myers CR; Zielonka J; Weh K; Chang AC; Chen G; Kresty L; Kalyanaraman B; You M
Nat Commun; 2019 May; 10(1):2205. PubMed ID: 31101821
[TBL] [Abstract][Full Text] [Related]
16. A Vanadium-Based Nanoplatform Synergizing Ferroptotic-like Therapy with Glucose Metabolism Intervention for Enhanced Cancer Cell Death and Antitumor Immunity.
Zhang Y; Du X; He Z; Gao S; Ye L; Ji J; Yang X; Zhai G
ACS Nano; 2023 Jun; 17(12):11537-11556. PubMed ID: 37272777
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis in cancer and cancer immunotherapy.
Zhao L; Zhou X; Xie F; Zhang L; Yan H; Huang J; Zhang C; Zhou F; Chen J; Zhang L
Cancer Commun (Lond); 2022 Feb; 42(2):88-116. PubMed ID: 35133083
[TBL] [Abstract][Full Text] [Related]
19. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
